Article summary

Bit Bio announces agreement with Abcam, a global innovator in life science reagents and tools, to make Bit Bios iPSC derived functional human cells widely available to the global life science community. The first product available are brain cells (ioNEURONS/glutTM, glutamatergic neurons) serving the neuroscience community. [] Access to human cells is a significant bottleneck in the field of medical research and drug development. [] Bit Bio is commercializing opti-ox TM , a precise reprogramming proprietary technology platform that enables uniquely efficient and consistent production of human cells for use in research, drug discovery, and cell therapy. [] Abcams reputation as a disruptive innovator in the field of biological reagents and dedicated global commercialization infrastructure make them the ideal partner. In line with our core value of democratizing access to human cells for research and drug development, our ioNEURONS/glut are offered at a highly competitive price point.

Click here to read the full article

See the original post:
Bit Bio Secures Distribution Agreement with Abcam to Democratize Access to Human Cells for Global Life Science Research - Gooruf